THORACIC NEOPLASMS
Clinical trials for THORACIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new THORACIC NEOPLASMS trials appear
Sign up with your email to follow new studies for THORACIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Last-Chance drug access for tough lung cancer cases
Disease control NO_LONGER_AVAILABLEThis program provided access to the experimental drug taletrectinib for patients with advanced ROS1-positive lung cancer who had run out of approved treatment options and couldn't join regular clinical trials. The program was designed for people whose cancer had spread and who co…
Matched conditions: THORACIC NEOPLASMS
Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Apr 04, 2026 01:50 UTC
-
Real-World test for advanced lung cancer treatment combo
Disease control OngoingThis study is observing how well a combination of the drug Osimertinib and standard chemotherapy works for people with a specific type of advanced lung cancer (EGFR-positive NSCLC) in a real-world setting. It involves 532 adult patients who have already started this specific trea…
Matched conditions: THORACIC NEOPLASMS
Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Can better doctor training save more lung cancer patients?
Knowledge-focused OngoingThis study aims to see if providing standardized training to cancer doctors in smaller city and county hospitals leads to better testing and treatment for patients with advanced non-small cell lung cancer. It will follow 1,000 patients to measure if doctors order more recommended…
Matched conditions: THORACIC NEOPLASMS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC